ELVN
Enliven Therapeutics Inc
NASDAQ · Pharmaceuticals
$29.42
+2.43 (+9.00%)
Open$27.45
Previous Close$26.99
Day High$30.22
Day Low$27.13
52W High$30.22
52W Low$13.30
Volume—
Avg Volume945.7K
Market Cap1.75B
P/E Ratio—
EPS$-1.85
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+7.6% upside
Current
$29.42
$29.42
Target
$31.67
$31.67
$20.91
$31.67 avg
$36.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 263.34M | 235.73M | 210.63M |
| Net Income | 79.58M | 63.75M | 57.56M |
| Profit Margin | 30.2% | 27.0% | 27.3% |
| EBITDA | 141.73M | 119.11M | 111.32M |
| Free Cash Flow | 52.28M | 61.02M | 35.31M |
| Rev Growth | -0.5% | +12.7% | -7.4% |
| Debt/Equity | 0.42 | 0.43 | 0.43 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |